Market Analysis and Insights: Global and United States Computational Medicine and Drug Designing Software Market
This report focuses on global and United States Computational Medicine and Drug Designing Software market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Computational Medicine and Drug Designing Software market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Cloud-based accounting for % of the Computational Medicine and Drug Designing Software global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Drug Discovery and Development was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Computational Medicine and Drug Designing Software market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Computational Medicine and Drug Designing Software Scope and Market Size
Computational Medicine and Drug Designing Software market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Computational Medicine and Drug Designing Software market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Computational Medicine and Drug Designing Software market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Cloud-based
On-premise
Segment by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences